Too Good to Be True? Evaluation of Colonoscopy Sensitivity Assumptions Used in Policy Models.
Carolyn M RutterPedro Nascimento de LimaJeffrey K LeeJonathan OzikPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Misspecification of either colonoscopy sensitivity or disease progression in high-risk populations may affect the predicted effectiveness of colorectal cancer screening. When possible, decision analyses used to inform policy should address these uncertainties.See related commentary by Etzioni and Lange, p. 702.